Skip to main content

Vogelxo FDA Approval History

FDA Approved: Yes (First approved June 4, 2014)
Brand name: Vogelxo
Generic name: testosterone
Dosage form: Transdermal Gel
Company: Upsher-Smith Laboratories Inc.
Treatment for: Hypogonadism, Male

Vogelxo (testosterone) transdermal gel is an androgen indicated for testosterone replacement therapy in males with hypogonadism.

Development timeline for Vogelxo

Jun  5, 2014Approval Upsher-Smith Receives Final NDA Approval For Vogelxo (testosterone) Gel

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.